Regentatlantic Capital LLC decreased its position in Monsanto Company (NYSE:MON) by 3.0% during the second quarter, Holdings Channel reports. The fund owned 1,958 shares of the basic materials company’s stock after selling 60 shares during the period. Regentatlantic Capital LLC’s holdings in Monsanto were worth $232,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. Puplava Financial Services Inc. raised its position in shares of Monsanto by 0.4% in the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock worth $251,000 after buying an additional 9 shares during the last quarter. Delta Asset Management LLC TN raised its position in shares of Monsanto by 0.5% in the first quarter. Delta Asset Management LLC TN now owns 1,950 shares of the basic materials company’s stock worth $221,000 after buying an additional 10 shares during the last quarter. Savant Capital LLC raised its position in shares of Monsanto by 0.4% in the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock worth $349,000 after buying an additional 11 shares during the last quarter. Guardian Life Insurance Co. of America raised its position in shares of Monsanto by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock worth $191,000 after buying an additional 11 shares during the last quarter. Finally, Greenwich Wealth Management LLC raised its position in shares of Monsanto by 0.6% in the first quarter. Greenwich Wealth Management LLC now owns 2,565 shares of the basic materials company’s stock worth $290,000 after buying an additional 15 shares during the last quarter. Institutional investors own 75.31% of the company’s stock.

Shares of Monsanto Company (MON) traded down 0.260% during midday trading on Thursday, reaching $117.035. 740,225 shares of the company’s stock traded hands. The stock has a 50-day moving average price of $117.49 and a 200-day moving average price of $115.01. Monsanto Company has a 52-week low of $97.35 and a 52-week high of $118.97. The stock has a market cap of $51.42 billion, a P/E ratio of 25.278 and a beta of 1.07.

Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.19. The firm had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.17 EPS. Analysts forecast that Monsanto Company will post $4.89 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Stockholders of record on Friday, July 7th were paid a $0.54 dividend. The ex-dividend date of this dividend was Wednesday, July 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. Monsanto’s dividend payout ratio is currently 46.75%.

COPYRIGHT VIOLATION NOTICE: “Regentatlantic Capital LLC Cuts Stake in Monsanto Company (NYSE:MON)” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.watchlistnews.com/regentatlantic-capital-llc-cuts-stake-in-monsanto-company-nysemon/1471225.html.

A number of research firms recently weighed in on MON. UBS AG downgraded shares of Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. BidaskClub downgraded shares of Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Wednesday, June 21st. Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a research note on Tuesday, June 27th. Finally, Susquehanna Bancshares Inc reissued a “neutral” rating and set a $128.00 price target (up from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have assigned a buy rating to the stock. Monsanto presently has a consensus rating of “Hold” and an average price target of $123.15.

In other news, SVP Janet M. Holloway sold 3,337 shares of Monsanto stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $118.00, for a total value of $393,766.00. Following the completion of the sale, the senior vice president now owns 44,405 shares in the company, valued at approximately $5,239,790. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert T. Fraley sold 52,410 shares of Monsanto stock in a transaction on Monday, July 10th. The shares were sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. Insiders sold a total of 74,470 shares of company stock valued at $8,791,281 in the last quarter. 0.79% of the stock is currently owned by company insiders.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.